Streetbeat News

Products Services

MSOS

Dr. Chanda Macias advocates for open access to medicine, emphasizing the importance at the Cannabis Capital Conference. The conference offers live access for existing subscribers and instant access for new users. MSOS, a US-listed ETF, may be indirectly impacted by the discussions and viewpoints shared at the conference.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 6:34 pm

MSOS

At Benzinga's Cannabis Capital Conference, Women Grow CEO Dr. Chandra Macias highlighted the challenges of international market expansion for cannabis companies, including cultural barriers and the need for language translation of contracts and understanding patient needs.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 6:33 pm

TONUSD

The TON Foundation reports significant growth in Toncoin (TON), attributing it to its increasing integration within Telegram, which boasts over 800 million users. TON's value surged by 54% in the past month, reaching an all-time high of over $7 and entering the top 10 cryptocurrencies by market capitalization. This growth is linked to Telegram's advertising revenue-sharing system and the Open League program, both of which utilize TON. Additionally, the TON Foundation's collaboration with HashKey Group to facilitate fiat to digital asset conversion in the Asia Pacific region and the introduction of a new identity verification system are highlighted as key developments.

Portfolio Pulse from Khyathi Dalal

April 16, 2024 | 6:30 pm

ABBV

AVTX

LLY

NVS

Oppenheimer upgraded Avalo Therapeutics Inc (AVTX) after its acquisition of an ex-Eli Lilly drug, AVTX-009, for hidradenitis suppurativa (HS). The drug is Phase 2-ready and shows promise in the competitive HS market, with a potential expansion into ulcerative colitis. Avalo announced a $185 million private placement to fund development. The analyst set a $35 price target, anticipating a 15% market penetration and a $75,000 launch price in 2029. AVTX shares rose 13.9% to $17.36.

Portfolio Pulse from Vandana Singh

April 16, 2024 | 6:25 pm

CURLF

MSOS

Boris Jordan emphasized the importance of market leaders in the cannabis industry to act as educators, highlighting the shift from a 50% medical business to a now predominantly adult-use driven market. He also noted that in Europe, the cannabis market is entirely medical. The article suggests watching the Cannabis Capital Conference live for more insights, indicating relevance for CURLF and MSOS investors.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 6:23 pm

CURLF

MSOS

Boris Jordan discussed the differences in consumer values towards THC between Europe and the U.S., noting that European values are not as prevalent as in the U.S. The U.S. is also experiencing a strategic shift in this context. The discussion was part of the Cannabis Capital Conference, accessible to subscribers and new users through provided links.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 6:23 pm

CSX

CSX, in partnership with Canadian Pacific Kansas City (CPKC), has unveiled its first hydrogen-powered locomotive, a significant step towards sustainable freight transportation. This innovation, developed at CSX's Huntington, W.Va. shop, showcases CSX's commitment to environmental stewardship and marks a milestone in utilizing hydrogen as a cleaner, efficient alternative to fossil fuels. The locomotive, converted from diesel using a CKPC-developed kit, will undergo field testing to evaluate its performance and operational feasibility.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 6:21 pm

CURLF

MSOS

Boris Jordan, associated with Curaleaf, mentioned that following an acquisition in Canada, the company now has business operations in Australia and New Zealand. They are focusing on these markets to make Curaleaf's brands the most recognizable in the cannabis space.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 6:20 pm

CURLF

MSOS

Boris Jordan has announced the acquisition of a company to expand into the European market, focusing on EUGMP certified cannabis flowers and controlling the full supply chain for both flower and product sides. The announcement was made in the context of promoting the Cannabis Capital Conference, which offers live access for both existing and new subscribers.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 6:19 pm

GOOGL

META

Stifel analyst Mark Kelley maintained a Buy rating on Alphabet Inc (GOOG/GOOGL) and raised the price target from $154 to $174, citing growth in mobile search, YouTube, and programmatic advertising, along with investments in AI and other areas. Kelley views Google's AI capabilities and leadership in search and online video as key strengths, dismissing competitive threats as overdone. He also noted increased investments in Google and Meta Platforms Inc (META), emphasizing the importance of premium video ads and Google's advantage in CTV and premium video ad inventory over Meta. Kelley expects Alphabet's shares to continue re-rating positively due to its AI and CTV prospects.

Portfolio Pulse from Anusuya Lahiri

April 16, 2024 | 6:19 pm